Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
- PMID: 22722028
- PMCID: PMC3474950
- DOI: 10.1016/j.neuropharm.2012.06.001
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
Abstract
Anxiety disorders are characterized by persistent, excessive fear. Therapeutic interventions that reverse deficits in fear extinction represent a tractable approach to treating these disorders. We previously reported that 129S1/SvImJ (S1) mice show no extinction learning following normal fear conditioning. We now demonstrate that weak fear conditioning does permit fear reduction during massed extinction training in S1 mice, but reveals specific deficiency in extinction memory consolidation/retrieval. Rescue of this impaired extinction consolidation/retrieval was achieved with d-cycloserine (N-methly-d-aspartate partial agonist) or MS-275 (histone deacetylase (HDAC) inhibitor), applied after extinction training. We next examined the ability of different drugs and non-pharmacological manipulations to rescue the extreme fear extinction deficit in S1 following normal fear conditioning with the ultimate aim to produce low fear levels in extinction retrieval tests. Results showed that deep brain stimulation (DBS) by applying high frequency stimulation to the nucleus accumbens (ventral striatum) during extinction training, indeed significantly reduced fear during extinction retrieval compared to sham stimulation controls. Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of valproic acid (a GABAergic enhancer and HDAC inhibitor) or AMN082 [metabotropic glutamate receptor 7 (mGlu7) agonist], while MS-275 or PEPA (AMPA receptor potentiator) failed to affect extinction acquisition in S1 mice. Collectively, these data identify potential beneficial effects of DBS and various drug treatments, including those with HDAC inhibiting or mGlu7 agonism properties, as adjuncts to overcome treatment resistance in exposure-based therapies. This article is part of a Special Issue entitled 'Cognitive Enhancers'.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures







Similar articles
-
Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.Neuropharmacology. 2013 Jan;64:424-31. doi: 10.1016/j.neuropharm.2012.07.045. Epub 2012 Aug 7. Neuropharmacology. 2013. PMID: 22992332 Clinical Trial.
-
Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.Neuropharmacology. 2013 Jan;64(1):403-13. doi: 10.1016/j.neuropharm.2012.06.007. Epub 2012 Jun 18. Neuropharmacology. 2013. PMID: 22722027 Free PMC article.
-
Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.Neuropharmacology. 2013 Mar;66:274-89. doi: 10.1016/j.neuropharm.2012.05.025. Epub 2012 May 27. Neuropharmacology. 2013. PMID: 22643400 Free PMC article.
-
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?Biochem Soc Trans. 2014 Apr;42(2):569-81. doi: 10.1042/BST20130233. Biochem Soc Trans. 2014. PMID: 24646280 Free PMC article. Review.
-
The use of cognitive enhancers in animal models of fear extinction.Pharmacol Biochem Behav. 2011 Aug;99(2):217-28. doi: 10.1016/j.pbb.2011.01.009. Epub 2011 Jan 20. Pharmacol Biochem Behav. 2011. PMID: 21256147 Review.
Cited by
-
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders.Neuropsychiatr Dis Treat. 2020 Mar 2;16:597-606. doi: 10.2147/NDT.S242040. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32184601 Free PMC article. Review.
-
GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Acta Pharmacol Sin. 2018 May;39(5):733-753. doi: 10.1038/aps.2017.172. Epub 2018 Mar 22. Acta Pharmacol Sin. 2018. PMID: 29565038 Free PMC article. Review.
-
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.Curr Neuropharmacol. 2016;14(1):55-71. doi: 10.2174/1570159x13666151021111609. Curr Neuropharmacol. 2016. PMID: 26487502 Free PMC article. Review.
-
Stress and Fear Extinction.Neuropsychopharmacology. 2016 Jan;41(1):58-79. doi: 10.1038/npp.2015.180. Epub 2015 Jun 24. Neuropsychopharmacology. 2016. PMID: 26105142 Free PMC article. Review.
-
Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.Int J Neuropsychopharmacol. 2016 Jun 1;19(6):pyv128. doi: 10.1093/ijnp/pyv128. Print 2016 Jun. Int J Neuropsychopharmacol. 2016. PMID: 26625894 Free PMC article.
References
-
- Akirav I., Raizel H., Maroun M. Enhancement of conditioned fear extinction by infusion of the GABA agonist muscimol into the rat prefrontal cortex and amygdala. Eur. J. Neurosci. 2006;23:758–764. - PubMed
-
- Baetz M., Bowen R.C. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can. J. Psychiatry Revue canadienne de psychiatrie. 1998;43:73–77. - PubMed
-
- Bantscheff M., Hopf C., Savitski M.M., Dittmann A., Grandi P., Michon A.M., Schlegl J., Abraham Y., Becher I., Bergamini G., Boesche M., Delling M., Dumpelfeld B., Eberhard D., Huthmacher C., Mathieson T., Poeckel D., Reader V., Strunk K., Sweetman G., Kruse U., Neubauer G., Ramsden N.G., Drewes G. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 2011;29:255–265. - PubMed
-
- Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000;283:2529–2536. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous